After discontinuing medicine, most unwanted symptoms will disappear within a few weeks
Shen X, Pan D, Gong Q, Gu Z, Luo K
Gradual progression prevents the common pattern of early overexuberance followed by setback
For driver mutation-dependent tumors, targeted drugs should be combined to interrupt the rigid coupling between oncogenic mutations and metabolic activation
It can also enhance electrostatic interactions with cell surfaces and, importantly, possesses polycationic properties, making it a promising drug carrier for various applications[145]
Chronic PCSK9 inhibitor therapy leads to sustained improvements in endothelial function, arterial stiffness, and microvascular function